WNT5A has anti-prostate cancer effects in vitro and reduces tumor growth in the skeleton in vivo.

WNT5A has anti-prostate cancer effects in vitro and reduces tumor growth in the skeleton in vivo.

Item
http://www.wikidata.org/entity/Q38956252
Wnt5a Signaling in CancerA novel non-canonical Wnt signature for prostate cancer aggressiveness.Estrogen related receptor alpha in castration-resistant prostate cancer cells promotes tumor progression in boneQuantitative Proteomics Reveals Fundamental Regulatory Differences in Oncogenic HRAS and Isocitrate Dehydrogenase (IDH1) Driven Astrocytoma.Treatment with the WNT5A-mimicking peptide Foxy-5 effectively reduces the metastatic spread of WNT5A-low prostate cancer cells in an orthotopic mouse model.WNT signalling in prostate cancer.WNT5A induces castration-resistant prostate cancer via CCL2 and tumour-infiltrating macrophages.WNT5A and Its Receptors in the Bone-Cancer Dialogue.Frizzled Receptors as Potential Therapeutic Targets in Human Cancers.Role of WNT5A receptors FZD5 and RYK in prostate cancer cells.TET1 exerts its anti-tumor functions via demethylating DACT2 and SFRP2 to antagonize Wnt/β-catenin signaling pathway in nasopharyngeal carcinoma cells
P2860

WNT5A has anti-prostate cancer effects in vitro and reduces tumor growth in the skeleton in vivo.

Item
http://www.wikidata.org/entity/Q38956252
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
WNT5A has anti-prostate cancer ...... rowth in the skeleton in vivo.
@en
type
label
WNT5A has anti-prostate cancer ...... rowth in the skeleton in vivo.
@en
prefLabel
WNT5A has anti-prostate cancer ...... rowth in the skeleton in vivo.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P356
P1433
P1476
WNT5A has anti-prostate cancer ...... rowth in the skeleton in vivo.
@en
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698